Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Jiafen
    Member
    • Oct 2012
    • 14

    TruSeq Adaptors reported by FastQC are true adaptors?

    I asked a question about using fastx_clipper to get rid of the adaptor sequence last time and it did not work.

    I googled TruSeq adaptor sequences (http://www.omicsoft.com/downloads/ng...on_list/v1.txt) and compared them with our reported TruSeq Adaptors. Because our sequences have length between 49-52, all reported adaptor have length 50. I choose the first 50 nt from TruSeq adaptor to compare with ours, the results are as follows:
    4 reported TrueSeq Adaptors are exactly the same as the first 50nt of TruSeq adaptor;
    3 reported TrueSeq Adaptors have almost the same sequence as the first 50 nt except the 42nd nt, they all replace A by C;
    2 reported TrueSeq Adaptors, their 2nd-50 nt are the same as TruSeq Adaptor 1-49nt

    I decided to try to align my reads without get rid of adaptor sequence by novoalign (using default setting) to see whether those sequences reported as TruSeq Adaptors are in the result of alignment. Unfortunately, they are. But if I specify the reported adaptor sequence as adaptor in novoalign, these sequence will be removed.

    So my questions now is whether those sequences reported as TruSeq Adaptor by FastQC are true Adaptor sequences or not?
  • pbseq
    Member
    • Feb 2010
    • 16

    #2
    If Ii remind correctly fastQC allows for some mismatches , you may also wish to compare identified adapters to fastQC database contaminants within fastQC folder
    Pbseq

    Comment

    • simonandrews
      Simon Andrews
      • May 2009
      • 870

      #3
      FastQC allows some flexibility in its matches, it also doesn't require a match to exist over the whole length of the sequence. The summary of the match will tell you how good a match it actually found.

      Many of the illumina adapters are very similar to each other, differing by only a few bases so FastQC often finds a multitude of possible hits, so it just picks the first of the best set of hits to report.

      Given that the program only does these searches for sequences which occur at very high levels in a library it's pretty unusual to get a complete false positive for the presence of an adapter sequence, although the identification of the exact adapter used may well not be correct.

      Comment

      • Jiafen
        Member
        • Oct 2012
        • 14

        #4
        Thank you very much, Simon. That makes more sense to me.

        I want to correct the observation I mentioned earlier. I double checked manuscript of novoalign, the reported adaptor sequences are not aligned to any region, I am assuming they are true adaptors.


        Originally posted by simonandrews View Post
        FastQC allows some flexibility in its matches, it also doesn't require a match to exist over the whole length of the sequence. The summary of the match will tell you how good a match it actually found.

        Many of the illumina adapters are very similar to each other, differing by only a few bases so FastQC often finds a multitude of possible hits, so it just picks the first of the best set of hits to report.

        Given that the program only does these searches for sequences which occur at very high levels in a library it's pretty unusual to get a complete false positive for the presence of an adapter sequence, although the identification of the exact adapter used may well not be correct.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          Today, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 11:10 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        39 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...